Gonzaga, Ariane Myrl A.
HRN: 29-92-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2026
CEFUROXIME 750MG (VIAL)
07/14/2026
07/21/2026
IV
750mg
Q8h
Avulsed Wound Right Arm
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes